Microbiome-metabolome dysbiosis of bronchoalveolar lavage fluid of lung cancer patients
Frontiers in Microbiology · 12.11.2025 · 16
DOI: 10.3389/fmicb.2025.1669172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.11.2025. Verfasst von Jing Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Beijing Chaoyang Sanhuan Cancer Hospital, Beijing, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Recent studies indicate that microorganisms significantly influence lung cancer pathogenesis. This research explores the variations in microbiota and metabolites in the lower respiratory tract between lung cancer patients and individuals with benign pulmonary lesions to identify potential diagnostic biomarkers.
Methods
Two hundred eight patients undergoing bronchoscopy at Tianjin Cancer Institute & Hospital and Tianjin Chest Hospital from October 2022 to October 2023 were screened. Ninety-five bronchoalveolar lavage fluid (BALF) was collected for metagenomic sequencing and untargeted metabolomic analysis. Comparisons of microbial diversity, taxonomic composition, and metabolite profiles were conducted between groups with lung cancer and benign lung conditions.
Results
The cohort comprised 70 patients with lung cancer and 25 with benign lung lesions. Patients with lung cancer showed significantly reduced β -diversity ( p = 0.005). Predominant microbes in lung cancer cases included Streptococcus , Haemophilus influenzae , and Veillonella parvula . A microbial-based diagnostic model differentiated lung cancer from benign lesions with an AUC of 0.931 (95%CI: 0.916–0.946). Metabolites increased in lung cancer were Citric acid, N-Acetylneuraminic acid, Oxoglutaric acid, and Neopterin, whereas L-Tryptophan, Uridine, 3-Hydroxybutyric acid decreased. The KEGG pathways suggest a significant link between microbial presence and both tumorigenesis and progression.
Conclusion
Specific microbial patterns in the lower respiratory tract of lung cancer patients could assist in the auxiliary diagnosis of the disease. The notably altered microorganisms and metabolites in the BALF from lung cancer patients, as opposed to those with benign conditions, correlate with cancer initiation and advancement.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Beijing Chaoyang Sanhuan Cancer Hospital, Beijing, China.
- Department of Endoscopy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, China Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center…
- Department of Respiratory and Critical Medicine, Tianjin Chest Hospital, Affiliated Chest Hospital of Tianjin University, Tianjin, China.
- Vision Medicals Center for Infectious Diseases, Guangzhou, China.
- Center for Precision Cancer Medicine & Translational Research, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medica…
- Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zitieren
APA
Wang, J., Su, W., Chen, Q., Zhou, J., Wang, X., Jiang, R., Li, J., & Xing, P. (2025). Microbiome-metabolome dysbiosis of bronchoalveolar lavage fluid of lung cancer patients. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1669172
Vancouver
Wang J, Su W, Chen Q, Zhou J, Wang X, Jiang R, et al. Microbiome-metabolome dysbiosis of bronchoalveolar lavage fluid of lung cancer patients. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1669172
BibTeX
@article{Wang2025,
author = {Wang, Jing and Su, Wei and Chen, Qin and Zhou, Jiemin and Wang, Xinyue and Jiang, Richeng and Li, Junling and Xing, Puyuan},
title = {Microbiome-metabolome dysbiosis of bronchoalveolar lavage fluid of lung cancer patients},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1669172}
}
EUVIMED